Erin Van Winkle
About Erin Van Winkle
Erin Van Winkle serves as the Senior Director of Clinical Development at Adaptimmune US, a position she has held since 2015. With a background in clinical research spanning over two decades, she has held various roles at notable companies including PAREXEL, AstraZeneca, Duramed Pharmaceuticals, and Shire Pharmaceuticals.
Current Role at Adaptimmune
Erin Van Winkle serves as the Senior Director of Clinical Development at Adaptimmune US. She has held this position since 2015, contributing to the company's clinical strategies and development processes. Her role involves overseeing clinical trials and ensuring compliance with regulatory standards, which are critical for the advancement of Adaptimmune's therapeutic programs.
Previous Experience in Clinical Development
Prior to her current role, Erin Van Winkle accumulated extensive experience in clinical development across several organizations. She worked at Shire Pharmaceuticals as Associate Director of Clinical Programs from 2009 to 2015. Before that, she was a Senior Clinical Program Manager at Duramed Pharmaceuticals from 2005 to 2009 and a Senior Clinical Research Scientist at AstraZeneca from 2002 to 2005. Her career began at PAREXEL, where she worked as a Clinical Research Associate from 1999 to 2002.
Educational Background in Biology
Erin Van Winkle earned her Bachelor of Science (B.S.) in Biology from Loyola University Maryland. She studied at the university from 1995 to 1999, laying the foundation for her career in clinical development and research. This educational background has equipped her with the necessary knowledge and skills to excel in her roles within the pharmaceutical industry.